Product Description
| Brand | Abbott |
| Sample Type | Venous EDTA Plasma |
| Pack Size | 50T |
| CAT No | 270150050 |
The m-PIMA HIV-1/2 VL test is now commercially available in select countries, and has received CE-IVD marking and WHO prequalification.
Rapid and Accurate HIV MonitoringThe m-PIMA HIV-1/2 Viral Load Test delivers precise quantification of viral RNA with a quick processing time of around 70 minutes per test. Its high accuracy meets WHO standards, making it an essential tool for monitoring HIV progression and managing patient treatments in a timely fashion. The portable design and automatic operation enable its effective use in various clinical and point-of-care settings.
User-Friendly, Portable DesignDesigned for ease of use, the device features an intuitive touchscreen interface, built-in printer, and multi-language support. Its lightweight and compact build (about 5 kg) allows for simple relocation and setup, even in remote locations. With data storage for up to 500 results and options for USB or Wi-Fi connectivity, it streamlines workflow for healthcare providers.
Built-In Quality and Reliable PerformanceEach test incorporates internal quality controls to ensure reliable outcomes, while factory calibration eliminates the need for frequent user intervention. The device uses high-grade medical materials for durability and operates with low noise. It is CE-IVD certified, ensuring compliance with international standards for laboratory devices.
FAQ's of Abbott m-PIMA HIV-1/2 VIRAL LOAD TEST:
Q: How does the Abbott m-PIMA HIV-1/2 Viral Load Test work?
A: The m-PIMA test uses real-time PCR technology to quantitatively analyze HIV-1/2 RNA in EDTA plasma samples. The sample-in to result process is fully automated, taking approximately 70 minutes to provide a result, which is displayed on the digital touchscreen and can be printed instantly.
Q: What are the benefits of using the m-PIMA device in remote or resource-limited settings?
A: This device is lightweight and portable, suitable for both bench-top and point-of-care use. Its rechargeable battery, low power consumption, and user-friendly interface make it ideal for deployment in remote or urban locations. Minimal training is required and no manual calibration is needed, streamlining HIV monitoring in diverse settings.
Q: When and where can I use the m-PIMA HIV-1/2 Viral Load Test?
A: The device is intended for use in medical laboratories or point-of-care environments, including remote or urban settings. It can be used whenever quantification of HIV-1/2 viral load is required for patient monitoring and disease management, providing reliable results within 70 minutes.
Q: What sample type and cartridge are required for testing?
A: Testing requires EDTA plasma as the sample type and the m-PIMA HIV-1/2 VL Cartridge, which is specifically designed for the instrument to ensure optimal compatibility and accurate results.
Q: How are results stored and retrieved on the device?
A: Up to 500 test results can be stored internally. Data is accessible via the touchscreen interface and can be exported through USB or optional Wi-Fi connectivity, supporting record-keeping and further data analysis.
Q: What quality control measures are in place with each test?
A: Each test includes internal controls to validate the integrity and accuracy of every analysis. The factory calibration guarantees consistently high performance without the need for manual adjustment.